| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/08/2004 | CA2490138A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 01/08/2004 | CA2489660A1 Drug composition for prevention or inhibition of advance of diabetic complication |
| 01/08/2004 | CA2489376A1 Methods of organ regeneration |
| 01/08/2004 | CA2488703A1 Food and beverage product for stimulating gastrointestinal mobility |
| 01/08/2004 | CA2488526A1 Stable liquid parenteral parecoxib formulation |
| 01/07/2004 | EP1378572A1 Bmp-11 compositions |
| 01/07/2004 | EP1378510A1 Triazaspiro 5.5]undecane derivatives and drugs containing the same as the active ingredient |
| 01/07/2004 | EP1377834A2 Medicaments which are modulators of hm74 and/or hm74a activity |
| 01/07/2004 | EP1377676A2 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 01/07/2004 | EP1377610A2 Osteoprotegerin in milk |
| 01/07/2004 | EP1377609A2 Mhc molecule constructs and their uses for diagnosis and therapy |
| 01/07/2004 | EP1377593A2 2-amino-propanol derivatives |
| 01/07/2004 | EP1377589A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 01/07/2004 | EP1377587A1 Protein phosphate inhibitors |
| 01/07/2004 | EP1377584A1 Novel cyclohexenyl phenyl diazepines as vasopressin and oxytocin receptor modulators |
| 01/07/2004 | EP1377576A2 Pyridine derivatives |
| 01/07/2004 | EP1377573A2 Pyrazolopyridine derivatives |
| 01/07/2004 | EP1377572A1 Isoxaxole derivatives as inhibitors of src and other protein kinases |
| 01/07/2004 | EP1377569A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations |
| 01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 01/07/2004 | EP1377560A1 Piperazine derivatives as tachykinin antagonists |
| 01/07/2004 | EP1377555A1 Novel compounds |
| 01/07/2004 | EP1377550A1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
| 01/07/2004 | EP1377540A1 INHIBITORS OF INTEGRIN AvB6 |
| 01/07/2004 | EP1377339A2 Method for preventing acute renal failure |
| 01/07/2004 | EP1377310A2 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof |
| 01/07/2004 | EP1377295A2 Carboxamide derivatives as therapeutic agents |
| 01/07/2004 | EP1377164A1 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 01/07/2004 | EP1294388B1 Extracts from sophora species, method for producing the same and their use |
| 01/07/2004 | EP1175417B1 Substituted benzolactam compounds |
| 01/07/2004 | EP1034187B1 Growth-promoting proteins and peptides for kidney epithelial cells |
| 01/07/2004 | EP0748315B1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at1 and at2, these products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same |
| 01/07/2004 | CN2596986Y Prostatitis paster |
| 01/07/2004 | CN1466586A Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 01/07/2004 | CN1466580A Thiazole or oxazole derivatives |
| 01/07/2004 | CN1466576A Quinolne-(C=O)-CD1, tri-and tetrapeptide) derivatives as caspase inhibitors |
| 01/07/2004 | CN1466573A 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis |
| 01/07/2004 | CN1466463A Remedies for ischemic diseases |
| 01/07/2004 | CN1466451A Ion-strength independent sustained release pharmacetuical formulation |
| 01/07/2004 | CN1465369A Chinese medicine Wuxingsan powder and its preparation method |
| 01/07/2004 | CN1133635C Cyanopyrroles as progesterone receptor agonists |
| 01/07/2004 | CN1133449C Pill for moistening kidney and replenishing marrow |
| 01/07/2004 | CN1133447C Pure Chinese medicine prepn. for fast strengthening yang and tonifying kidney |
| 01/07/2004 | CN1133434C Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 01/07/2004 | CN1133427C Solid oral dosage forms of valsartan |
| 01/06/2004 | US6673931 (4-(4-(3-(2-methoxy-benzyloxy)-propoxy)-phenyl)-5-(4-methoxy -naphthalen-2-ylmethoxy)-piperidin-3-yl)-methanol for example; use treating restenosis, glaucoma, cardiac and kidney insufficiency |
| 01/06/2004 | US6673838 Succinate salt of O-desmethyl-venlafaxine |
| 01/06/2004 | US6673803 Quinazoline derivatives and pharmaceutical compositions containing them |
| 01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 01/06/2004 | US6673796 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/06/2004 | US6673794 Substituted aminomethyl-phenyl-cyclohexane derivatives |
| 01/06/2004 | US6673780 Such as 4-(4-(3-hydroxy-3-methyl-butane-1-sulfinylmethyl)-phenylmethanesulfinyl)-2 -methyl-butan1-ol for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 01/06/2004 | US6673377 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 01/06/2004 | CA2223588C Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1375465A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |
| 01/02/2004 | EP1374869A1 Novel use of arylethene sulfonamide derivative |
| 01/02/2004 | EP1373517A2 Human kinases |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1373287A1 Process for obtaining lignan, pharmaceutical compositions and uses thereof |
| 01/02/2004 | EP1373263A1 Heterocyclic compounds for aging-related and diabetic vascular complications |
| 01/02/2004 | EP1373258A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 01/02/2004 | EP1373242A1 Dimeric isoflavones |
| 01/02/2004 | EP1373240A2 Retinoid x receptor modulators |
| 01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 01/02/2004 | EP1373223A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/02/2004 | EP1373205A1 Novel piperidine derivatives as modulators of chemokine receptors |
| 01/02/2004 | EP1373203A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
| 01/02/2004 | EP1373191A1 Acylated indanyl amines and their use as pharmaceuticals |
| 01/02/2004 | EP1373158A2 Additives for building industry obtained from by-products and process for their production |
| 01/02/2004 | EP1372740A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions |
| 01/02/2004 | EP1372735A2 Conjugate of hydroxyalkyl starch and an active agent |
| 01/02/2004 | EP1372695A2 Cell damage inhibitor |
| 01/02/2004 | EP1372679A1 Bioactivity of methyl palmitate obtained from a mangrove plant salvadora persica l |
| 01/02/2004 | EP1372656A1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
| 01/02/2004 | EP1372654A2 Quinoline inhibitors of hyak1 and hyak3 kinases |
| 01/02/2004 | EP1372639A2 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia |
| 01/02/2004 | EP1372638A1 Functional role for cannabinoids in autonomic stability during sleep |
| 01/02/2004 | EP1372634A2 Fumaric acid amides |
| 01/02/2004 | EP1372630A2 Agent for the treatment of overactive bladder |
| 01/02/2004 | EP1372627A1 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/02/2004 | EP1372624A2 Tramadol-based medicament |
| 01/02/2004 | EP1372412A2 Composition improving age-related physiological deficits and increasing longevity |
| 01/02/2004 | EP0746343B1 Bioartificial kidney devices coated with cells suitable for use in vivo or ex vivo |
| 01/01/2004 | US20040002535 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 01/01/2004 | US20040002525 Obesity; osteoporosis |
| 01/01/2004 | US20040002524 Cardiovascular disorders; osteoporosis; central nervous system disorders |
| 01/01/2004 | US20040002521 Antiinflammatory agents; metalloprotease inhibitor; antiarthritic agents; antiallergens; viricides |
| 01/01/2004 | US20040002519 Mixture of hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, insulin elimination promoter and insulin sensitizer with carrier |
| 01/01/2004 | US20040002503 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 01/01/2004 | US20040002493 Benzoic acid derivatives and pharmaceutical agents comprising the same as active ingredient |
| 01/01/2004 | US20040002481 Novel 4-dedimethylaminotetracycline derivatives |
| 01/01/2004 | US20040002473 Pain modulation; incotinence therapy; central nervous system disorders |
| 01/01/2004 | US20040002134 Novel nucleic acid sequences encoding human KIAA0768 protein-like and human protein PRO228-like polypeptides |
| 01/01/2004 | US20040002113 Detection and treatment methods for type I diabetes |